Russell Frank Company’s Cumberland Pharmaceuticals CPIX Stock Holding History

Russell Frank Company’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$23K	Hold	5,198	–	–	﹤0.01%	2924
2015 Q4	$27K	Hold	5,198	–	–	﹤0.01%	2937
2015 Q3	$30K	Hold	5,198	–	–	﹤0.01%	2947
2015 Q2	$37K	Hold	5,198	–	–	﹤0.01%	2983
2015 Q1	$35K	Buy	+5,198	New	+$32.4K	﹤0.01%	2834
2013 Q3	–	Sell	-67	Closed	–	–	3452
2013 Q2	$0	Buy	+67	New	+$333	﹤0.01%	3355

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Russell Frank Company's CPIX Position: Q1 2016 in Review

Russell Frank Company held its Cumberland Pharmaceuticals (CPIX) position steady in Q1 2016 at 5,198 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.

Russell Frank Company first reported a position in CPIX in Q2 2013 and has held it in 6 quarters since. The position peaked at $37K in Q2 2015. 48 funds tracked by Wall St. Rank hold CPIX as of Q1 2016.

Russell Frank Company held 5,198 shares of Cumberland Pharmaceuticals worth $23K as of Q1 2016.
Russell Frank Company left its Cumberland Pharmaceuticals share count unchanged in Q1 2016.
Cumberland Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2924 holding.
Russell Frank Company first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
Russell Frank Company's Cumberland Pharmaceuticals position peaked at $37K in Q2 2015.
48 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.